Med. praxi. 2016;13(2):61-62 | DOI: 10.36290/med.2016.012

Pharmacotherapy in low back pain

MUDr.Marek Hakl, Ph.D.
Oddělení léčby bolesti FN Brno

Increasing number of patients with low back pain can be seen in developed countries. The greatest impact on this state has a

sedentary lifestyle with no or irregular physical activity. It should be noted that the pharmacotherapy of low back pain treatment

is a symptomatic therapy and the first treatment step should be done by man himself by reflecting on own lifestyle and not to

underestimating right and especially regular physical activity.

Keywords: low back pain, non-opioid analgesics, opioids, muscle relaxants

Published: May 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hakl M. Pharmacotherapy in low back pain. Med. praxi. 2016;13(2):61-62. doi: 10.36290/med.2016.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adamová B. Bolesti páteře. In: Hakl M. a kol, Léčba bolesti. Praha: Mladá fronta, 2013: 170-182.
    2. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom. Manage. 2004; 28: 140-175. Go to original source... Go to PubMed...
    3. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 2003; 28: 1978-1992. Go to original source... Go to PubMed...
    4. Slíva J. Myorelaxancia ve světle Evidence Based Medicíny. Practicus 2008; 5: 27-29.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.